Humoral immune response to tumor antigens after treatment with cancer antigen-specific active immunotherapy and its relevance to improved clinical outcome

摘要

Provided herein are compositions and methods for predicting treatment outcome by measuring a patient's response to cell antigen specific active immunotherapy (CASAI) using pre-determined biomarkers.